Matthias Therapeutics, LLC
Summary
Matthias Therapeutics, LLC raised $65.0M in an initial Form D filing on 2026-06-01, with Flagship Pioneering and ARCH Venture Partners as related persons. The large raise and top-tier VC involvement signal strong investor confidence in the company's technology venture. The filing is a first notice, with no prior amendments.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Full Analysis
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Dare Bioscience, Inc.
Uniform Bio Inc.
DEF 14A - Outlook Therapeutics, Inc.
Anika Therapeutics, Inc.
Outlook Therapeutics, Inc.
Strategy Inc
Pacira BioSciences, Inc.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Promoting Advanced Artificial Intelligence Innovation and Security
This executive order directs multiple federal agencies to prioritize cybersecurity hardening of national security, Department of War, and civilian government systems within 30 days. It establishes a classified benchmarking process for 'covered frontier models' and a voluntary framework for AI developers to provide early access to such models to the government for cybersecurity purposes. It also creates an AI cybersecurity clearinghouse, expands cybersecurity hiring pathways, and directs enforcement against AI-enabled computer crimes.
Approving Critical Position Pay Authority for National Security Investment Workforce
This memorandum authorizes the Office of Personnel Management to allocate up to 400 critical positions with pay up to $400,000 to recruit specialized talent for national security investment programs, focusing on critical minerals, advanced materials, and strategic supply chains. It directs OPM and OMB to oversee allocation and ensure pay is used only to recruit or retain exceptionally qualified individuals. The action aims to accelerate domestic mineral production and reduce foreign dependence.
Integrating Financial Technology Innovation into Regulatory Frameworks
This executive order directs federal financial regulators to review and streamline regulations that hinder fintech innovation, particularly for small and emerging firms, and requests the Federal Reserve to evaluate expanding access to its payment accounts and services for non-bank and digital asset firms. It aims to reduce barriers to entry and encourage partnerships between fintech firms and traditional financial institutions, with specific deadlines for reviews and reports.